These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32247549)

  • 1. Phylogeny-Guided Approach Yields Glycopeptides with Unique Action.
    Cheng AV; Wuest WM
    Trends Pharmacol Sci; 2020 May; 41(5):297-299. PubMed ID: 32247549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling.
    Culp EJ; Waglechner N; Wang W; Fiebig-Comyn AA; Hsu YP; Koteva K; Sychantha D; Coombes BK; Van Nieuwenhze MS; Brun YV; Wright GD
    Nature; 2020 Feb; 578(7796):582-587. PubMed ID: 32051588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraction and Analysis of Peptidoglycan Cell Wall Precursors.
    Binda E; Carrano L; Marcone GL; Marinelli F
    Methods Mol Biol; 2016; 1440():153-70. PubMed ID: 27311671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by van gene homologue expression directing the synthesis of a modified cell wall peptidoglycan.
    Beltrametti F; Consolandi A; Carrano L; Bagatin F; Rossi R; Leoni L; Zennaro E; Selva E; Marinelli F
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1135-41. PubMed ID: 17220405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis.
    Singh M; Chang J; Coffman L; Kim SJ
    J Phys Chem B; 2017 Apr; 121(16):3925-3932. PubMed ID: 28368603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics.
    Reynolds PE; Somner EA
    Drugs Exp Clin Res; 1990; 16(8):385-9. PubMed ID: 2151441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
    Reynolds PE
    Eur J Clin Microbiol Infect Dis; 1989 Nov; 8(11):943-50. PubMed ID: 2532132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycopeptide antibiotics and their novel semi-synthetic derivatives.
    Jeya M; Moon HJ; Lee KM; Kim IW; Lee JK
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1194-204. PubMed ID: 21470154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry.
    Chang JD; Foster EE; Thadani AN; Ramirez AJ; Kim SJ
    J Bacteriol; 2017 Aug; 199(15):. PubMed ID: 28507244
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Gómez-Arrebola C; Hernandez SB; Culp EJ; Wright GD; Solano C; Cava F; Lasa I
    Microbiol Spectr; 2023 Aug; 11(5):e0037023. PubMed ID: 37646518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.
    Grein F; Schneider T; Sahl HG
    J Mol Biol; 2019 Aug; 431(18):3520-3530. PubMed ID: 31100388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics.
    Stegmann E; Frasch HJ; Kilian R; Pozzi R
    Int J Med Microbiol; 2015 Feb; 305(2):190-5. PubMed ID: 25601631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycopeptide antibiotics: a mechanism-based screen employing a bacterial cell wall receptor mimetic.
    Rake JB; Gerber R; Mehta RJ; Newman DJ; Oh YK; Phelen C; Shearer MC; Sitrin RD; Nisbet LJ
    J Antibiot (Tokyo); 1986 Jan; 39(1):58-67. PubMed ID: 3949630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.
    Koehl JL; Muthaiyan A; Jayaswal RK; Ehlert K; Labischinski H; Wilkinson BJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3749-57. PubMed ID: 15388430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Isakova EB; Reznikova MI; Goldman RC; Branstrom AA; Baizman ER; Longley CB; Sztaricskai F; Batta G; Preobrazhenskaya MN
    J Med Chem; 2002 Mar; 45(6):1340-7. PubMed ID: 11882003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycopeptide antibiotic resistance.
    Pootoolal J; Neu J; Wright GD
    Annu Rev Pharmacol Toxicol; 2002; 42():381-408. PubMed ID: 11807177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance.
    Zeng D; Debabov D; Hartsell TL; Cano RJ; Adams S; Schuyler JA; McMillan R; Pace JL
    Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27663982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Properties, and Mechanism of Action of New Generation of Polycyclic Glycopeptide Antibiotics.
    Olsufyeva EN; Tevyashova AN
    Curr Top Med Chem; 2017; 17(19):2166-2198. PubMed ID: 28137232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
    Ślusarz R; Szulc M; Madaj J
    Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bacterial cell wall as a source of antibacterial targets.
    Green DW
    Expert Opin Ther Targets; 2002 Feb; 6(1):1-19. PubMed ID: 11901475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.